Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

CARE Ratings Ltd (CREI)

NSE
Currency in INR
Disclaimer
1,153.65
+8.45(+0.74%)
Real-time Data

CREI Comments

when to buy and sell
buy around ,652 target 1000
Buy JAYSREETEA at 122-125 Short term target 140 to 150 long term target 180 to 400++ ( Huge demand of tea )
stock headed towards 1000 /-
Good for medium termCare ratings limitedBuy above 5401 month target 700Stoplos 490
buy 469 target 600
Care rating is nearing resistance area profit booking could be seen range 668 to 689 can test 600 resistance at 699. short term
CARE RATING looks good range 956 to 900 can test 1140 support at 865. Long term
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.